SLN Competitors & Alternatives
Compare Silence Therapeutics PLC with similar stocks in the same industry
Biotechnology
SLN
Main Stock$19.67
Tradestie Score
31
Market Cap
$240.89M
Revenue Growth
2.0%
Analyst Upside
+0.4%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$10.19
|
$1.29B | - | 44 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$24.98
|
$1.29B | - | 53 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.04
|
$1.29B | - | 57 | Compare |
|
ZYME
Zymeworks Inc.
|
$28.13
|
$1.28B | - | 47 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$4.55
|
$1.27B | - | 58 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 54 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$7.35
|
$1.22B | - | 44 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$6.17
|
$1.18B | - | 62 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$41.16
|
$1.17B | - | 65 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$20.64
|
$1.15B | 4.9 | 47 | Compare |
More SLN Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry